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INTRODUCTION 
INTRODUCTION
Administration of the drug via the mucosal layer is a novel method that can
render treatment more effective and safe, not only for the topical diseases but also for
systemic ones. These unique dosage forms, which can be applied on a wet tissue, are
formulated by utilizing the adhesive properties of some water - soluble polymers.
The study shows the anti inflammatory action loaded in the patches which will be
reducing the paining of the mouth in adults which compared in different water soluble
mucoadhesive polymers.
The mucosal  layer  lines  a  number  of  regions  of  the  body  including  the
gastrointestinal tract, buccal cavity, airways, ear, nose, eye, urogenital tract, vagina and
rectum are covered with a thick gel like structure known as mucin, therefore all bio-
adhesives must interact  with  the mucin layer during the process of attachment, these
represent the potential sites for attachment of any bioadhesive system.1,2
Special features of mucoadhesive dosage forms
-  For  the  drugs  with  bioavailability  problems,  they  localize  the  drug  in  a
particular region, there by improving and enhancing the bioavailability3.
-  The strong interaction between the polymer and the mucosal lining of the
tissue, help to increase the contact time and permits localization, an essential
issue when modification of tissue permeability is important for drug delivery.
eg:- Peptides,  proteins and ionized species.
-  To inhibit metabolizing enzymes in a localized area.
-  To deliver agents locally for the purpose of modulating antigencity.
-  Because of the dual biophysical and biochemical nature of these mucosal
membranes, drugs with hydrophilic or lipophilic characteristic can be readily
absorbed.
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-  It   has   an   advantage   of   bypassing   the   hepatogastrointestinal   first-pass
elimination associated with oral administration.
From  the  view  point  of  drug  administration,  oral  mucosa  offers  various 
advantages:
-  Because  of  its  accessibility,  it  permits  localization  of  controlled  delivery
system and allows opportunity to locally modify tissue permeability, inhibit
protease activity or decrease immunogenic response.
-  It can be easily removed in case of emergency,
-  It offers a passive system which does not require activation.
-  It  by-passes  hepatic  first  pass  metabolism  there  by  offering  a  greater
availability and reduction in dosage.
-  It can be made unidirectional to ensure only buccal absorption.
-  The buccal mucosa is highly perfused with blood vessels and offers a greater
permeability than the skin.
-  The oral mucosa lacks prominent mucus secreting goblet cells and there by
diffusion limited mucus build up over time; beneath a mucoadhesive drug
delivery device applied to the oral mucosa does not pose a problem.
-  Drug is not subjected to the destructive acidic environment of the stomach and
enzymatic alkaline environment of the intestine also, drugs showing poor and
erratic absorption from the stomach can be given via this route.
-  Therapeutic serum concentration of the drug can be achieved more rapidly.
-  The  presence  of  saliva  ensures  relatively  large  amount  of  water  for  drug
dissolution unlike in case of rectal and transdermal routes.
-  Side effects can be reduced by this route which are associated with other
routes of drug administration4,5,6.
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Buccal Mucoadhesive Drug Delivery System i.e. the drug delivery via oral mucosa
has several advantages.
Which are as follows:
-  It avoids the first pass metabolism.
-  The absorption of drug is quick and provides immediate relief alternative to the
oral route.
-  An alternative to injection form7.
Inspite of all these advantages, there are several limitations :
-  Once placed at the absorption site the patch should not be disturbed.
-  Eating and drinking are restricted until complete absorption has taken place.
-  Patient compliance is difficult to achieve.
-  Properties like unpleasant taste or odour, irritability to the mucosa, stability at
buccal pH etc., pose limitations to the choice of drug, along with their physico
chemical limitations4.
Oral mucosal delivery :
Drugs can  be  absorbed  from the  oral  cavity  through  the  oral  mucosa  either
sublingually or buccally. In general, rapid absorption from these routes is observed.      
 The oral  cavity is  lined  by a relatively thick, dense and  multilayered  mucous
membrane with high vasculature. Drugs entering into the membrane can find access to the
systemic circulation via network of capillaries and arteries. The arterial flow is supplied
by branches of external carotid artery. The venous back flow goes via capillaries and the
venous network is finally taken up by the Jugular vein.
The equally developed lymphatic drainage runs more or less parallel to the
venous vascularization and ends up in the Jugular ducts. Thus, the buccal & sublingual
routes can be used to by- pass hepatic first pass elimination8.
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Fig: Drug Absorption In The Oral Cavity
Drug absorption  into  the  mucosa  is  mainly  via  passive  diffusion  into  the
lipoidal   membrane. Compounds with favorable o/w partition coefficient are readily
absorbed  through  oral  mucosa.  Compounds  administered  by  either  the  buccal  or
sublingual   routes   include  steroids,   barbiturates,   papain,   trypsin  and  streptokinase,
streptoclornase. Besides transcellular diffusion, there   is evidence that water soluble
molecules with molecular volume less than 80 cm3/mol cross primarily through
membrane pores and large water soluble molecules pass paracellularly.   Regardless of
polarity, large molecules are poorly absorbed9.
Conventional, buccal and sublingual dosage forms are typically short acting
because of limited contact time between the dosage form and the oral mucosa6. Since
sublingual administration   of   drugs interfere with eating, drinking and talking, this
route is generally considered unsuitable   for   prolonged administration. On the other
hand,  the  duration  of  buccal  drug  administration  can  be  prolonged  with  saliva
activated adhesive troches without the problem of sublingual   administration. The
polymers that are used are usually water-soluble and will attach to the related tissues or
to the surface coating of the tissue. Since these polymers become adhesive upon
hydration, they are called wet adhesives.
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"Mucoadhesive  drug  delivery  systems  may  be  defined  as  drug  delivery
systems  which  utilize  property  of  bioadhesion  of  certain  water  soluble  polymers
which become adhesive upon hydration and hence can be used for targeting a drug to a
particular region of the body for extended period of time."
In general, the permeabilities of the oral mucosa decreases in the order of
sublingual >buccal> palatal. The distinct problems that are present in the sublingual
route like the drug dissolving in the saliva and unpleasant taste and odour felt by the
patient are absent in the buccal mucoadhesive route3
A. Human Oral Mucosa:
Oral mucosal delivery has been practiced for many years as evidenced by the
development of such pharmaceutical dosage form as sublingual tablets and lozenges.
These oral products have been available for several decades and are commonly used for
delivering organic based   pharmaceuticals to the oral mucosa for either local or
systemic medication10.
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Fig 1: Cross section of oral mucosa
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B. Physiological and Anatomical Characteristics of Mucosa:
Oral mucosa is a lining tissue that serves to protect the underlying tissues. It
consists of two parts; the underlying epithelium and the connective tissues.  The
epithelium of the  oral   cavity is in principle similar to that of the skin, with
interesting differences regarding keratinization and the protective and lubricant mucus
spread across its surface. The total area is about 100 cm2, the buccal part with about
one third of the total surface is lined with an epithelium of about 0.5 mm thickness
and the rest by one of 0.25 mm thickness. The multi-layered structure of   the oral
mucosa is formed by cell divisions which occur mainly in the basal layer. The mucosa of
the oral cavity can be divided into three functional zones.
-  The mucus secreting regions consisting of the soft palate, the floor of the
mouth, the under surface of the tongue, the labial and buccal mucosa. It has a
normally non-keratinized epithelium. These regions are supposed to represent
the major absorption sites in oral cavity.
-  The hard palate and the gingiva are the regions of masticatory mucosa and
have a normally keratinized epidermis.
-  Specialized zones and borders of the lips and the dorsal surface of the tongue
with its highly sensitive keratinization.
An important feature of the buccal membrane is the presence of numerous
elastic fibers in the dermis, which provide its typical elastic and robust behavior.
These fibers represent another effective barrier against the diffusion of drug
molecules into   the circulation system. The buccal mucosa has also more glycogen
granules and numerous ribosomes. The surface of the mucus membrane is constantly
washed by a stream of about 0.5 up to 1 lt of saliva daily.
Transport of the drug through oral mucosa is most likely to occur mainly
through the   non-keratinized sections. The first efficient barrier against penetration,
however, is the mucin layer covering the oral epithelium. It consists of glycoproteins.
Two transport routes seem to operate by I) Trans cellular route 2) Para cellular route.
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Fig 2: Schematic representation of penetration routes in buccal drug delivary
C. Biochemical Characteristics:
Although the biochemical composition of nasal, rectal and vaginal epithelium
has not been well characterized, the lipid composition of other mucosal epithelia,
including the buccal mucosa and alimentary tract, have been analyzed.
Mucus is a translucent and viscid secretion which forms a thin, continuous layer
adherent to the mucosa epithelial surface. It is secreted by goblet cells, lining the epithelia
or by special exocrine glands with mucus cells acini. The exact composition of the mucus
layer  varies  substantially depending  on  the  species,  the  anatomical  location  and  the
pathophysiological state. However, it has the following general composition.
D. Mucosol Metabolis:
Drugs may be subjected to metabolism during the course of transmucosal
permeation,  either  in  the  mucosal  surface  microenvironment  or  in  the  mucosal
membrane. Peptidases have been noted to be present in the non-oral mucosa including
nasal, rectal and vaginal mucosal homogenates. The ability of the amino peptidases to
hydrolyze encephalins was greater in the rectal mucosa than in the nasal and vaginal
mucosa
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E. Mucosal Membrane Models:
It  has  been  generally  accepted  that  the  biological  membrane  can  be
represented  by  Singer  and  Nicolsan.  The  following  figure  is  a  two  dimensional
representation of this model,  which depicts a biological membrane composed of a
fluid state lipid bilayer embedded with globular integral proteins.
Fig 3:The fluid mosaic model proposed by Singer and Nicolson  for the structure of 
epithelial  membrane,  consists  of  amphipathic  globular  integral  protein  molecules 
embedded in the fluid state lipid bilayer.
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In the following figure, the integral proteins are shown to be either embedded in
a portion of the lipoidal membrane or spanning through out its entire thickness. The
amphiphilic protein molecules   have been hypothesized to minimize the free energy
required   for   transmembrane  permeation  by   maximizing  both  hydrophilic   and
lipophilic interactions in the membrane.
Fig 4: Two thermodynamically favored structures of the globular integral protein
molecule.
(A) Monodisperse structure in which the hydrophilic component (H) is exposed to the
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aqueous   environment on the surface of epithelial membrane and the lipophilic
component (L) is embedded in the lipid bilayer.
(B) Subunit aggregate structure in which a subunit aggregate of two protein molecules
spanning through the entire thickness of the lipid bilayer to form an aqueous solution
filled pore channel11.
Factors Affecting Buccal Absorption
The oral cavity is a complex environment for drug delivery as there are  many
dependent and independent factors which reduce the absorbable concentration at the site
of absorption.
Membrane factors:
This  involves  the  degree  of  keratinization,  surface  area  available  for 
absorption,   mucus  layer  or  salivary  pellicle,  intercellular  lipids  of  epithelium, 
basement  membrane  and  lamina  propria.  In  addition,  the  absorptive  membrane 
thickness, blood supply/ lymph drainage,  cell renewal and enzyme content will all 
contribute  in  reducing  the  rate  and  amount  of  drug  entering  in  to  the  systemic 
circulation .
Enviornmental factor                     
- Saliva:   The  thin  film  of  saliva  coats  throughout   the  lining  of   buccal
mucosa is called salivary pellicle or film. The thickness of salivary film is
0.07 to 10mm. The thickness, composition and movement of this film
effects buccal absorption .
-  Salivary glands:  The minor salivary glands are located in epithelial or deep
epithelial region of buccal mucosa. They constantly secrete mucous on surface
of buccal mucosa.   Although, mucous helps to retain mucoadhesive dosage
forms. It is a potential barrier to drug penetration.
-  Movement of oral tissues:   Buccal region of oral cavity shows less active
movement.  The  muucoadhesive  polymers  are  to  be  incorporated  to  keep
dosage  form  at  buccal  region  for  long  periods  while  withstanding  tissue
Ultra college of pharmacy, Madurai Page 11
INTRODUCTION 
movement during talking and if possible during eating food or swallowing
BIOADHESION
Bioadhesion is an interfacial phenomena in which two materials at least one of
which is biological are held together by means of interfacial forces. The attachment
could be between an  artificial  material and  biological  membrane.  In  the  case  of
polymer  attached  to  the  mucin  layer  of  mucosal  tissue,  the  term  mucoadhesion
employed.
MECHANISM OF BIOADHESION :
For bioadhesion to occur, a succession of phenomenon whose role depends on the
nature of the bioadhesive is required.
-  The first stage involves an intimate contact between a bioadhesive and a
membrane, either from a good wetting of the bioadhesive surface or from the
swelling of the bioadhesive.
-  In the second stage, after contact is established, penetration of the bioadhesive
into the tissue surface of inter penetration of the chains of the bioadhesive with
those of the mucus takes place low chemical bonds can then settle.
On a molecular level mucoadhesion can be explained based on molecular
interaction.   The   interactions between two molecules is composed of attraction and
repulsion. Attractive interaction arise from vanderwaal forces, electrostatic attraction,
hydrogen bonding and hydrophobic interaction. Repulsive interactions occur based on
electrostatic and stearic repulsion.
Theories of Bioadhesion:
Several theories have been proposed to explain the fundamental mechanisms of
adhesion. In a particular system, one or more theories can equally well explain or
contribute to the formation of bioadhesive bonds.
1.  Electronic theory:
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According to the electronic theory,  electron transfer  occurs upon contact  of an
adhesive polymer with a mucous glycoprotein network because of differences in their
electronic structures.  This  results  in the formation of an electrical  double layer  at  the
interface. Adhesion occurs due to attractive forces across the double layer.
2.  Adsorption theory:
According to the adsorption theory after an initial contact between two surfaces,
the  material  adhers  because  of  surface  forces  acting  between  the  atoms  in  the  two
surfaces. Two types of chemical bonds resulting from these forces can be distinguished.
a.  Primary chemical bonds of covalent nature, which are undesirable in
mucoadhesion  because their high strength may result in permanent bonds.
b.   Secondary chemical bonds having many different forces of attraction including
electrostatic forces, Vanderwaals forces and hydrogen and hydrophobic bonds.
3.  Diffusion theory:
According to  diffusion  theory,  the  polymer  chains  and  the  mucous,  mix  to a
sufficient depth to create a semitransparent adhesive bond. The exact depth   which
the   polymer  chains  penetrate  the  mucous  depends  on  the diffusion coefficient and
the time   of contact. This diffusion co-efficient, in turn,   depends   on   the   value   of
molecular  weight  between  cross  links  and decreases significantly as the cross linking
density increases.
4.  The wetting theory:
This theory  is  developed  predominantly  in  regard  to  liquid  adhesives,  uses
interfacial tensions to predict spreading and in turn adhesion. The study of surface energy
of both polymers and tissues to predict mucoadhesive performance.
5.   The fracture theory:
This theory analyses the forces required to separate two surfaces after adhesion.
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The  maximum tensile  stress (Sm) produced during detachment  can be determined by
dividing the maximum force of detachment fm , by the total surface area (Ao) involved in
the adhesive interaction
                                                             Sm = fm/Ao.
METHODS USED TO STUDY  BIOADHESION2
Several test methods have been reported for studying bioadhesion. These tests are
necessary not only to screen a large number of candidates to mucoadhesives, but also to
study their mechanisms. These tests are also important during the design and
development  of  a  bioadhesive controlled  release  system as  they ensure  compatibility,
physical and mechanical   liability, surface   analysis and   bioadhesive bond strength.
The test methods can broadly be classified into two major categories.
I ). In- vitro/ ex- vivo methods
II). In vivo methods
I): In – vitro / ex - vivo methods  :Most in- vitro methods are based on the
measurement   of either   tensile   or   shear   stress,  Bioadhesiveness   determined   by
measurement of stress tends to be subjective, since there is no standard test method
established for bioadhesion.
1. Methods based on measurement of tensile strength :
These methods usually measures the force required to break the adhesive bond
between a model membrane and the test polymers. The instruments usually employed are
Modified balance or tensile tester. A typical example is the method employed by
Robinson and his group. In this method, the force required to separate the bioadhesive
sample from freshly excised rabbit stomach tissue was determined using a modified
tensiometer.
2. Methods based on measurement of shear strength :
The shear strength measures the force that causes the bioadhesive to slide with
respect to the   mucous layer in a direction parallel to their plane of contact. An
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example is Wilthemy plate method reported by Smart et al. The method uses a glass
plate suspended from a microbalance   which   is dipped in a temperature controlled
mucous  sample  and  the  force  required  to  pull  the  plate  out  of  the  solution  is
determined under constant experimental conditions.
3. Other in- vitro methods :
A number of other methods including  adhesion weight method , fluorescent 
probe method, flow channel method, mechanical spectroscopic method, falling liquid 
film  method,  colloidal  gold  staining  method, thumb  test,  adhesion  number  and 
electrical conductance method.
II. In- vivo methods
Various methods for in-vivo evaluation of both placebo and drug containing 
mucoahesive  devices  in  healthy  human  volunteers  have  been  reported*  since  the 
literature.  Rathbone et al" have discussed several methods to study the rate and extent of 
drug loss from human oral mucosa.
1.4 Factors important to mucoadhesion:
The bioadhesive strength of a polymer or of a series of polymers is effected by the
nature of the polymer and also by the nature of he surrounding media.
1.  Polymer related factors:
a.  Molecular   weight:   The   optimum   molecular   weight   for   maximum
mucoadhesion depends on the type of mucoadhesive polymer at issue. It
isgenerally understood that the threshold required for successful mucoadhesion
is atleast 1,00,000 molecular weight.
b. Concentration of the active polymer: There is an optimum concentration of a
mucoadhesive  polymer  to  produce  maximum  mucoadhesive in highly
concentrated systems, beyond the optimum level,  however,   the   adhesive
strength  drops  significantly  because  the  coiled molecules become separated
from the medium so that the chains available  for  interpenetration  become
limited.
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c.  Chain flexibility:   Chain   flexibility   is   critical   for   interpenetration   and
enlargement. As water soluble polymers become crosslinked, mobility of
individual polymer chains   decrease and thus the effective length of the
chains that can penetrate into the   mucous   layer decreases, thus reduce
mucoadhesive strength.
2.  Environment related factors:
a. pH: pH can influence the formal charge on the surface of mucous as well as
certain ionisable mucoadhesive polymers. Mucous will have a different charge
density  depending  on  pH  due  to  difference  in  dissociation  of functional
groups on the carbohydrate moiety and the amino acids of the polypeptide
backbone.   Some  studies   have   shown  that   the   pH  of   the  medium  is
important  for  the  degree  of   hydration  of  cross  linked polyacelylic acid,
showing   consistantly increased hydration from pH- 4 to pH - 7 and then a
decrease  alkalinity and ionic strength increases.
b.  Contact time: Contact time between the mucoadhesive and mucus layer
determines the extent of swelling and interpretation of the mucoadhesive
polymer chains. More over, mucoadhesive strength increases as the initial
contact time increases.
c. Swelling : Swelling characteristics are related to the mucoadhesive itself and
its environment. Swelling depends on the polymer concentration, ionic strength
as well as presence of water. During the process of mucoadhesion,  maximum
mucoadhesion in vitro occurs with an optimum water content. Over  hydration
results  in  the  formulation  of  a  wet  slippery  mucilage without adhesion.
3.  Physiological variable: Mucin properties, turn over and disease started. In
many  routes of   administration, surface mucous is encountered by the
mucoadhesive before it relates the tissue. The extent of interaction between
the polymer and the  mucous depends on mucous viscosity, degree of
entanglement, and water content. How  long  mucoadhesive  remains  at   the
site  depends  on  whether  polymer  is soluble or insoluble in water and the
associated turnover rate of mucin. Estimates of  mucin  turnover  rate  widely,
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depending on the location and  method of measurement. The physicochemical
properties of the mucous are known to change during the disease conditions
such as the common cold , gastric ulcers, ulcerative colitis, cystic fibrosis,
bacterial and fungal infection of the female reproductive  tract,  and
inflammatory condition of the eye16.
BUCCAL ADHESIVE DOSAGE FORMS:
Definition
Buccal adhesive dosage forms are those dosage forms which can deliver drugs
either locally   to treat conditions within the buccal cavity or systemically via the
mucosa13
Requirement
It often  a   requirement  that   buccal-adhesive  dosage  forms  should  remain
adhesive and allow a controlled delivery of drug for prolonged periods. Therefore, for
sustained drug delivery,   buccal adhesive formulations must contain elements that
remain  adhesive  for  a  prolonged  period,  regulate  the  rate  and  direction  of  drug
delivery and, in order to allow both of the above mentioned, restrict the rate of water
ingress.
Types of formulations:
Buccal  –  adhesive  dosage  forms  can  be  divided  into  the  following  types  of
formulation.
Tablets: Tablets are dry dosage forms that may have to be moistened prior to placing
in contact with the buccal mucosa. The size of the tablet is restricted to that which can
be comfortably stained in place for prolonged periods.
Films:  Buccal patches are two ply laminated system, with an aqueous solution of the
adhesive polymer being cast onto an impermeable backing membranes. Three layered
tape dosage form has been described that consists of backing layer, a middle layer and an
adhesive layer. A bioadhesive multilayered extruded film has also been reported.*
Semisolid preparations: Ointments and gels are most widely used only for localized 
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drug therapy within the oral cavity.
Powders:  These   are   sprayed   onto   the   buccal   mucosa   but   potential   clinical
applications of this type of formulation is limited.
Buccal - Mucoadhesive Patches:
Requirement of buccal-adhesive patches:
-  They should be flexible enough to allow the movement of the cheek.
-  They should be adhesive enough to be retained to the buccal mucosa for at
least 6 hours.
-  The adhesion should not be so strong, that mucosa is damaged on removal of
the patch.
-  They  should  be  bio-compatible,  non-allergenic  and  should  not  cause  any
irritation.
-  The size of the patch may be 10-15 cm2   in size, but should be 1-3 cm2  so as
to be convenient and comfortable for the patient.
-  They should restrict the rate of water ingress.
Successful buccal patch should have following three criterias
a) A bioadhesive to retain drug in oral cavity and maximize the intimacy of contact
with mucosa.
b)  A vehicle  that  releases  the  drug at  an  appropriate  rate  under  the  condition
prevailing in the mouth.
c) Strategies for overcoming the low permeability of oral mucosa.
Buccal mucoadhesive dosage forms can be categorized into three types based on their
geometry :-
TYPE I:
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It is a single layer devise with multidirectional drug release. This type of dosage
form suffers from significant drug loss due to swallowing. 
TYPE II:
It is a device in which an impermeable backing layer is superimposed on top of 
the drug loaded bioadhesive layer, creating a double layered device and preventing drug 
loss from the top surface into the oral cavity. 
TYPE III:
It is a unidirectional drug release device, from which drug loss is minu mal, since 
the drug is released only from the side adjacent to the bucal mucosa. This can be achieved
by coating every face of the dosage form, except the one that is in contact with the buccal 
mucosa.
METHODS OF PREPARATION OF PATCHES
Two methods are used to prepare adhesive patches.
1. Solvent casting
In this method, all patch excipients including the drug co-dispersed in an organic
solvent and coated onto a sheet of release liner. After solvent evaporation a thin layer of
the protective backing material is laminated onto the sheet of coated  release liner to form
a laminate that is die-cut to form patches of the desired size and geometry.
2. Direct milling
In this, patches are manufactured without the use of solvents. Drug and excipients
are mechanically mixed by direct milling or by kneading, usually without the presence of
any liquids. After the mixing process, the resultant material is rolled on a release liner
until  the  desired  thickness  is  achieved.  The  backing  material  is  then  laminated  as
previously  described.  While  there  are  only  minor  or  even  no  differences  in  patch
performance between patches fabricated by the two processes, the solvent-free process is
preferred because there is no possibility of residual solvents and no associated solvent-
related health issue.
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MUCOADHESIVE POLYMERS
Mucoadhesive polymers are water soluble and water insoluble polymers which are
swellable networks jointed by cross linking agents. The polymer should possess optimal
polarity to  make sure it  is sufficiently wetted by the  mucous and optimal  fluidity that
permits the mutual adsorption and interpenetration of polymer and mucous to take place.
Many mucoadhesive polymers are  made of either synthetic or natural polymers.
Most  of  the  current  synthetic  mucoadhesive  polymers  are  either  polyacrylic  acid  or
cellulose  derivatives.  Examples  are  carboxy methyl  cellulose,  carbopol-934P,
polycarbophil,  tragacanth,  sodium alginate,  hydroxy  ethyl  cellulose,  hydroxy  propyl
methyl  cellulose,  gum karaya,  gelatin,  guargum, pectin,  polyvinyl pyrrolidone,  acacia,
polyethylene glycol, chitosan and hydroxy propyl cellulose2.
BUCCAL ABSORPTION ENHANCERS
Penetration enhancers are the substances, which increases the buccal mucosal
membrane  permeation  rate.   Although  most   penetration  enhancers   were  originally
designed for the purpose other than absorption enhancement, as systemic search for
safe and effective penetration enhancers must be a priority in drug delivery18.
Examples of membrane permeation Enhancers:
a. Bile salts and other steroidal detergents
 Sodium glycocholate
 Sodium taurocholate
 Saponins.
b. Surfactants
(1) Nonionics:
Polysorbate 80
 Sucrose esters
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 Laureth – 9.
(2) Catoinic:
 Cetyltrimethylammonium.      
       (3) Anionic
 Other enhancers
 Salicylates
 Chelating agents
 Sulfoxides.
MECHANISM OF BUCCAL ABSORPTION ENHANCERS :
Mechanism by  which  penetration  enhancers  are  thought  to  improve  mucosal
absorption include the following:
-  Changing mucous rheology
-  Increasing fluidity of lipid bilayer membrane
-  Affecting the components involved in the formation of intracellular junctions.
-  Overcoming the enzymatic barrier.
-  Increasing the thermodynamic activity of drugs19.
KINETICS OF DRUGRELEASE:
Generally  it   is  understood  that  the  release  of  drug  from  films  can  be
considered as mass transport phenomenon involving diffusion of drug molecules from a
region of higher concentration in the dosage form to a region of low concentration in
the surrounding environment.   The kinetics of drug release from films have been
reported and  it was assumed that drug release was confined to any of the order such as
zero order or first order processes. One indication of mechanism can be obtained using
Ultra college of pharmacy, Madurai Page 21
INTRODUCTION 
a plot of log of cumulative percentage of drug remaining in the matrix against time.
First order release would be linear as predicted by following equation.
Log C = Log Co - Kt /2.303 ———-—————(1) Where, C = 
Amount of drug left in the matrix
Co =  Initial amount of drug in the matrix
K = First order rate constant, (time –1)
t = time, either in hours or minutes
The in-vitro drug release data obtained from all batches of compressed films was
treated according to equation (1) by plotting log of cumulative % of drug remaining
against time. These plots are shown in results and discussion section.
Next, an attempt was made to see whether the drug release is by diffusion. For
systems which will release the drug by diffusion were proposed by Higuchi.
Q=[De/T(2A-ecs)cst]1/2   ……………………(2)
Where, Q = Weight in grams of drug released per unit surface area.
D = Diffusion co-efficient of drug in the release medium. e = Porosity of the matrix.
Cs = Solubility of drug in the films expressed as grams per ml.
The assumption made in the deriving equation (2) are as follows: A pseudo steady state is 
maintained during release.
A » Cs i.e., excess solute is present.
C = 0 solution at all times (perfect sink).
Drug particles are much smaller than those in the matrix. The diffusion coefficient 
remains constant.
No interaction between the drug and the matrix occurs.
for the purpose of data treatment, equation is usually reduced to, Q = Kt1/2 ---------------
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(3)
Therefore a plot of amount of drug released verses the square root of time should be linear
if the drug release from the matrix is diffusion controlled. For the instances one  may
control the release from a homogenous matrix by varying the flowing parameters such as:
• Initial concentration of drug in matrix.
• Drug solubility.
• Porosity.
• Tortousity.
• Leaching solvent composition.
• Polymer system making up matrix.
In the present study, the release data obtained were plotted according to the
above equation. These graphs are shown in the results and discussion section.
Precisely, to know the exact mechanism of drug release, whether it is by diffusion or
with combination of both diffusion and erosion control, the data has also been plotted
according to   equation   as suggested by Korsemeyer. They used a simple empirical
equation to describe the general solute release behaviour from control release polymer
matrices.
Mt    = Kt
n ....
........................................(4)
M∞
Mt = the fraction of drug release
M∞
K = Kinetic rate constant t = Release time.
n = Diffusional exponent for drug release.
The value  of  'n' gives  an indication of the  release  mechanism.  When n=l  the
release rate is independent of time and is a desirable mechanism in oral controlled drug
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delivery, when   n=0.5 for fickian diffusion and when 0.5 < n < 1, the diffusion and non
fickian transport are implicated.
The in-vitro drug release data obtained from all formulations of films was
treated according to equation (4) by plotting log cumulative percentage of drug release
verses log  time. These plots are shown in results and discussion section.
Corticosteroids  are  the  drugs  used  for  the  management  of  many  oral
inflammatory40.  Corticosteroids  can  be  administered  intradentally,  topically  or
systemically.  Intradental or topical corticosteroids are preferred,  as those drugs can be
administered directly at the site of required action resulting in rapid action and minimal
chances  of  any  systemic  complications.  Topical  corticosteroids  are  widely  used  and
acceptable mode of treatment for vesiculo-erosive diseases of the oral mucosa including
oral lichen planus to reduce pain and inflammation. The most acceptable corticosteroid
therapy in the management of oral lichen planus is the topical treatment, because it is
easier  and  less  expensive  than  the  systemic  therapy  followed  by  topical  treatment.
Corticosteroids are used as dressing agents for cavities and exposed pulp which helps in
controlling the inflammatory pulp response and also in reduction of pain 20.
ORAL SUBMUCOUS FIBROSIS 
          Oral submucous fibrosis is an insidious, chronic, resistant diseases involving the
mucousa,  sub  mucous  or  any  part  of  the  oral  cavity  including  the  pharynx  and
eosophagus.  The disease produces excessive salivation, burning sensation, difficulty in
chewing,  swallowing and restricted mouth opening in  severe cases.  Various  treatment
modalities are used for the treatment of oral submucous fibrosis but application of steroid
ointment topically helps in cases with ulcers and painful oral mucosa. Such application
have  therapeutic  effects  and  mainly  shows  anti  inflammatory  activity  showing  anti
inflammatory activity showing a direct healing action on the mucosal patch.
ORAL LICHEN PLANUS 
Oral lichen planus is a common mucocutaneous disease. The condition can affect
either the skin or mucosa or both causing bilateral white striations. papules or plaques on
the buccal mucosa, tongue and gingival.
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Fig 5: Mucosal diseases
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I ) STUDIES ON STEROIDS
K.M.K.Masthan et el (2013) reported that the steroids helps in reducing inflammation.
Most  common  types  of  steroids  that  are  used  in  dentistry  are  hydrocortisone,
dexamethasone, methyl prednisolone and prednisolone. In dentistry, apart from surgeries,
steroids are widely used and accepted mode of treatment for oral mucosal lesions such as
oral lichen planus, oral submocous fibrosis, etc.
II ) STUDIES ON HYDROCORTISONE SODIUM SUCCINATE
Tank Nimit A et al (2001)  reported the formulation and evaluation of fast dissolving
tablets  of  hydrocortisone  sodium  succinate.  It  was  to  prepare  FDTs  containing
hydrocortisone sodium succinate using various super disintergrants by direct compression
method in different concentration..all the evaluations were evaluated. 
III) STUDIES ON BUCCAL PATCHES
C.Narendra  et al  (2005)   reported the development of three layered buccal compact
containing metapropolol tartarate by statistical optimazation technique. The objective of
this  work  to  evaluate  the  effect  of  formulation  variables  on  release  properties  and
bioadhesive  strength  in  development  of  three  layer  buccal  compact  containing
drug,formulation  were  prepared  based  on  rotatable  central  composite  design  with
peripheral polymer ratio (carbapol 934P: HPMC 4 KM ) and core polymer ratio (HPMC 4
KM : Sodium alginate) as two independent formulation variable.
Nova A.Nafee at al (2003) reported mucoadhesive buccal patches of miconazole nitrate:
invitro  /  in-vivo  performance  and  effect  of  aging.  Mucoadhesive  patches  containing
10mg,  micronazole  nitrates  were  evaluated.  The  patches  were  reported  with  ionic
polymer, SCMC and chitosan, non ionic polymers PVA,HEC and HPMC. The convenient
bioadhesion,  acceptable  elasticity,  swelling  and  surface  pH  were  obtained.  Patch
exhibited  sustained  release  over  more  than  5  Hrs.  and  addition  of  PVA generally
enchances the release rate.
       The optimum release behaviour was shown with patches containing 10% w/v PVA
and 5% w/v PVP.Storage of this patches did not affect the elastic properties, however
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enchance the release rate were observed due to marked changes in the crystal habits of the
drug.
Vishnu M.patel  et  al  (2007) reported effect  of  hydrophilic  polymers  on bioadhesive
eudragit patches of propanolol  hydrochloride using factorial design. The study was to
develop formulations and systematically evaluate invitro performance of buccoadhesive
patches of propanolol hydrochloride using hydrophobic polymer eudragit L-100 as the
base matrix. The hydrophobic polymer carbapol 934 and polyvinyl pyrolidone (PVP) k-
30 were incorporated in to the eudragit patches to provide the patches with bioadhesive
properties and to modify the rate of drug release..
Amir H.Shejao et  al  (1998)  reported transbuccal  delivery of  acyclovir  its  feasibility,
system design and invivo permeation studies. To design buccal mucoadhesive system for
systemic delivery of acyclovir was using a novel mucoadhesive, copolymers of acrylic
acid and poly (ethylene glycol) and to determine the feasibility of transbuccal delivery of
acyclovir.
R.C.Daoijad et al (2006)   reported buccoadhesive drug delivery system of isosorbide
dinitrate;  formulation  and  evaluation  in  the  form of  unidirectional  buccal  films  were
developed  and  characterized  for  improving  bioavailability.  Films  were  formulated  by
using different  bioadhesive  polymers  like  carbapol  934P and  polyvinyl  pyrolidine  by
using two different plasticizers propylene glycol and dibutylpthalate and characterized on
the basis of their physical characteristic, bioadhesive performance and other parameters.
In vitro studies revealed that the release that the release rate of isosorbid dinitrate was
higherfrom carbapol films containing ratio of eudragit RL 100and polyvinyl pyrolidine in
proportion of 1:2 and 1:2 respectively by using both plasticizers.
J.Ali  et  al  (2007)  reported buccoadhesive erodible disk  for  treatment  of  oro-dental
infection.Design and characterisation of cetyl pyridinium chloride were prepared by using
different  bioadhesive polymers along with excipients like mannitol.  The in vitro  drug
release was found to be 94.78% in 6 hrs.In situ release characteristics were evaluated
using  a  flow  through  assembly,which  simulated  the  conditions  of  the  human  buccal
cavity.
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A.Semalty et al (2005) reported design and evaluation of  mucoadhesive buccal films of
diltiazem hydrochloride were prepared by solvent casting technique using SCMC,PVP k-
30 and PVA and evaluated for their weight, thickness, surface pH, swelling index, in vitro
residence time, folding endurance, in vitro release permeation studies and drug content
uniformity, films exhibited controlled release over more than 6 hr.
J.Thimmasetty  et  al  (2008)   reported  design  and  evaluation  of  carvidilol  buccal
mucoadhesive patches,  was  prepared  using HPMC,  carbapol  934,eutragit  RS100,  and
ethyl cellulose. The patches were evaluated all the parameters. The invivo drug release
studies in rabbits shows 90.85% from HPMC and carbapol patch while it was 74.63 to
88.02% within 90 min in human volunteers.
D.Bhosle et al (2005)  reported the design and evaluation of sustained drug release of
buccal  mucoadhesive patches  of  chlorhexidine gluconate was prepared using polymer
such as HPMC, HES, and PVA by solvent casting method. All the parameters such as
were evaluated.
Satish babu B.K.et al (2008) reported the design and evaluation of atenolol patch. The
preparation of new bilayered devices comprising a drug containing mucoadhesive and
drug  free  backing  membrane.  Bilaminated  films  was  prepared  by  casting  method
containing the mixture of drug and sodium alginate with or without carbapol.
Y.Vamshi Vishnu et al (2007)  reported the development of mucoadhesive patches for
administration  of  carvidilol  by  using  two  different  mucoadhesive  polymers.  The
formulations were evaluated for invitro drug permeation., buccal absorption test, invitro
release studies, etc.
Jain-Haw Guo et al formulated   Buprenorphine   mucoadhesive   patch consisting of
poly isobutylene, poly isoprene and Carbopol 934p using a two-roll milling  method.
Carbopol  934p  was  the  bioadhesive  of  choice  for  the  current formulation because
it demonstrated a higher average peeling strength than hydroxyl  propyl methyl
cellulose, chitosan, or acacia as   measured during in-vitro testing. In- vitro analyses
showed that 75% of the buprenorphine was  released from the patch following 24 hrs
of incubation phosphate buffer at pH -7. It was also shown that patch adhesion increased
with increasing thickness and up to three minutes of aging had little effect on adhesive
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property.
Ilango R. et al  investigated the  possibility  of  obtaining  a  slow  release, relatively
constant  effective  levels  of glibenclamide  from  buccal  strips  using  chitosan.  They
found   that   chitosan-based  strips   of   glibenclamide   showed   better   results   than
Eudragit  based  glibenclamide buccal strips for controlled release behavior.
Wong C.F., et al fabricated mucoadhesive films using eudragit  NE40D and HPMC ,
SCMC and Carbopol of different grades, and investigated their  bioadhesive properties
as well as the rate of drug release, using metoprolol tartrate as the model drug. The in-
vitro drug release was determined using the USP 23   dissolution test apparatus. The
bioadhesive properties were evaluated  using the texture analyses   equipment with
chicken pouch as the model tissue. The incorporation of hydrophilic polymers was
found to affect the drug release as well as enhanced the bioadhesiveness.
Pandey S.,  e t  a l  prepared   buccal  mucoadhesive films and mucoadhesive gels of
theophylline   using hydroxy propyl methyl cellulose, ethyl cellulose and carbopol. The
drug release pattern and stability of the formulations were studied and found that   the
in-vitro drug   release and in- situ  intestinal  drug  absorption  were  higher  with
formulations containing carbopol.
Burgalassi S et al prepared and evaluated mucoadhesive patches for controlled release
of benzydamine  and   lidocaine.   The   patches   were   prepared   by   compressing
appropriate  mixtures containing the drug salts/complexes, a lactose and tamarind gum ,
were tested in-vitro  for mucoadhesion and drug release and   in-vitro   on human
volunteers for retention and release of benzydamine. The device containing the salts
of   benzydamine with pectin and polyacrylic acid and the complex of lidocaine with
tannicauid showed zero order release kinetics in vitro. The patches adhered for over 8hrs
to the upper gums of  the volunteers and were perfectly tolerated. Benzydamine
hydrochloride was released in vivo and in vitro with practically identical profiles.
Lalla  J  K.,et al  studied permeability  co-efficient,  flux  and  other  related  values  of
diclofenac   potassium through guinea pig buccal mucosa have been compared with
those obtained through procaine buccal mucosa at pH   6.8 and 8.0. The permeation
value of the species of diclofenac potassium have also been compared  with diclofenac
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diethyl ammonium salt.Permeability   co-efficient   values   were   significantly   higher
for   diclofenac potassium than those for diclofenac diethyl ammonium salt. Use of 5%
polysorbate 80 significantly enhanced the permeation of diclofenac potassium.
Noha Adel nafee,et  al prepared  mucoadhesive patches for delivery of cetyl
pyridinium chloride   using polyvinyl alcohol, hydroxy ethyl cellulose and chitosan.
Swelling  and   bioadhesive  characteristics  were  determined  for   both  plain  and
medicated  patches.  They  observed  remarkable  increase  in  radial  swelling  after
addition  of  the  water  soluble  drug  to  the  plain  formulae.  Polyvinyl  alcohol  and
chitosan containing formulae showed higher drug release as compared to HEC ones. A
considerable drop in release was observed for chitosan formulae after the addition of
water soluble additives, poly vinyl pyrrolidine and gelatin.
Nafee N.A.,   et al  prepared   and evaluated   mucoadhesive   patches   using   ionic
polymers,   sodium  carboxy  methyl cellulose and chitosan, and  non-ionic polymers,
polyvinyl alcohol, hydroxy propyl  methyl cellulose. Convenient bioadhesion,
acceptable elasticity, swelling and surface pH were obtained. Patch exhibited sustained
release over   more than 5 hrs and the  addition of polyvinyl pyrrolidone gently
enhanced the release rate. Optimum release  behaviour  was  shown  with  the  patch
containing 10% w/v PVA and 5% w/v PVP.
Perioli L,et  al prepared mucoadhesive films using several film-forming and
mucoadhesive  polymers.   The  film have  been  evaluated  in  terms  of  swelling,
mucoadhesion  and  organoleptic   characteristics.   The  film  contained   poly  vinyl
pyrrolidone and carboxy methyl cellulose sodium   salt was the best among others.
They were loaded with ibuprofen as a model drug and in-vitro and   in-vivo release
studies were performed.
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SCOPE OF THE WORK
Glucocorticoids  can  inhibit  or  suppress  the  inflammatory  responses  due  to
immunological  radiant,  mechanical,  chemical  and  infectious  stimuli  thereby  having
enormous clinical utility42.
     Corticosteroids can be administered intradentally, topically or systemically.  In the
treatment of oral and buccal inflammatory diseases, intradental or topical corticosteroids
are preferred, as those drugs can be administered directly at the site of required action
resulting in rapid action and minimal chances  of  any systemic complications.  Topical
corticosteroids are widely used and acceptable mode of treatment for vesiculo-erosive
diseases of the oral mucosa including oral lichen planus to reduce pain and inflammation.
The most acceptable corticosteroid therapy in the management of oral lichen planus is the
topical  treatment,  because  it  is  easier  and  less  expensive  than  the  systemic  therapy
followed by topical treatment. Corticosteroids are used as dressing agents for cavities and
exposed  pulp which  helps  in  controlling the  inflammatory pulp response  and  also  in
reduction of pain40.
 Topical corticosteroids remain the main stay of treatment and management of
aphthous ulcers  also43.  Topical  corticosteroids  are available as  oromucosal  dissolvable
tablets  and  pastes44.The  commonly  used  preparations  include  hydrocortisone  hemi-
succinate pellets 2.5 mg used 4 times daily, triamcinalone acetonide in carboxy methyl
cellulose paste administrated 4 times daily, or β-methasone sodium phosphate as a 0.5 mg
tablet  dissolved  in  15ml  of  water  to  make  the  mouth  rinse  used  4  times.  Especially
hydrocortisone  preparation  is  preferred  because  it  does  not  cause  significant  adrenal
suppression. Hydrocortisone sodium succinate is a natural glucocorticoid which is used
for the treatment of any inflammation and its related conditions43. Among glucocorticoids,
Hydrocortisone sodium succinate is the most suitable drug of choice to be used in the
buccal cavity.
Buccoadhesive patches are preferred in the local therapy of these oral lesions as
they can deliver the drug to the exact site of action as they are readily attached to the site
affected; retained for an appreciable length of time, and removed at any point of time.
Earlier,  buccal  patches  of   betamethasone  sodium  phosphate  was  prepared  and
investigated for oral submucosal fibrosis47.
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The present study was undertaken  to prepare and to evaluate  the buccal
patches of the   hydrocortisone sodium succinate used for the local  treatment of the
mucosal diseases.
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OBJECTIVE OF THE WORK
The main objective of the present work are
• To prepare the buccal patches of the Hydrocortisone sodium succinate with the
use  of   film forming polymer,  Eudragit  E100,  mucoadhesive  polymers  and  a
backing membrane.
• To evaluate the formulated patches for various characteristics and properties
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PLAN OF THE WORK
Plan of work is outlined below :-
I) Preformulation studies
a. Determination of solubility of drugs
b. Construction of standard curve of Hydrocortisone sodium succinate by UV 
 spectrophotometry
II) Fabrication of buccal patches
a.  Preparation and evaluation of drug loaded films
i) Preparation of drug loaded eudragit E 100 films.
ii) Evaluation of films for
a. Thickness
b. Folding endurance
c. Weight variation
d. Content uniformity
e. Surface pH
f. Swelling index
g. Tensile strength
h. Invitro drug release studies
          b. Preparation and evaluation of mucoadhessive layer of the patch
1. Preparation of mucoadhessive layer of the patch
            a. Carbopol-HPMC film
            b.Tamarind
            c. Sodium alginate
Ultra college of pharmacy, Madurai Page 35
SCOPE OBJECTIVE AND PLAN OF WORK
2. Characterisation of mucoadhessive layer
                   a. Thickness
            b. Weight uniformity
c.Folding Indurance.
d. Swelling Index
e.Mucoadhesive strength estimation
3. Preparation of Buccal patch (laminate) of  Hydrocortisone sodium 
succinate
               a. Preparation of  EC films ( Backing membrane )
               b. Preparation of laminate
         c. Evaluation
 1. ex vivo drug permeation studies.
2. Mucoadhesion studies.
3. In vivo compatibility studies.
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MATERIALS AND INSTRUMENTS USED
LIST OF MATERIALS
SL.NO Chemicals and reagents 
used
           Suppliers
           1 Hydrocortisone sodium    
                                  
Succinate
Oman pharmacy
               2  Eudragit E 100 Evonik
               3  Sodium alginate    Otto chemical 
biochemica-reagents            
               4
Carbapol S.d fine-chem Ltd mumbai
               5
Hydroxyl propyl    
      methyl cellulose
            15 cps
S.d fine-chem Ltd mumbai
               6
Ethyl cellulose Sd.fine-chem Ltd
               7
Poly ethylene glycol
       400LR
S.d fine-chem Ltd mumbai
               8
Iso propyl alcohol NICE chemicals P(Ltd) 
kerala
              9
Acetone               SRL
             10
Glycerine Paxmy specialitr chemicals
             11
Potassium dihydrogen ortho-
phosphate
   Otto chemical 
biochemica-reagents            
             12
Sodium hydroxide NICE chemicals P(Ltd) 
kerala
     LIST OF INSTRUMENTS
Sl.no               Name of 
instruments/Equipments
  Make and Model
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            1        Electronic balance SHIMADZU corporation 
Japan
            2
        
    Dissolution apparatus LAB INDIA
           3     UV-Visible double beam    
       spectrophotometer
SYSTRONICS
           4        Bath Ultrasonicator Confident ultra sonic
           5           FTIR Spectrum RXI
           6        Desiccator Sairam scientific
           7      Diffusion cell Modern scientific
           8      Screw gauge Bakar precision measuring 
instruments
           9      Magnetic stirrer Remi equipments P(Ltd)
         10     Texture Analyser Stable micro system, UK,
TA-XT
          11           Heating mantle Guna Enterprises Chennai
          12          Vacuum oven Shivani scientific industries 
P(Ltd) Bombay.
          13        Micro wave oven Magic cook Whirlpool
DRUG PROFILE
HYDROCORTISONE  SODIUM SUCCINATE 45,46       
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Category        : Anti-inflammatory, adrenocortical steroids. 
Chemical name   : Pregn-4-ene-3,20-dione,21-(3-carboxy-1- Oxopropoxy)-11,17  
  dihydroxy,monosodium salt,(11β). 
Mol. Formula       : C21H30O5. 
Mol.weight            : 484.51 
Solubility               : It is very soluble in water and in alcohol, very slightly soluble 
  incetone  and  insoluble in chloroform.
Bioavailability   : Readily absorbed after oral administration.
Plasma protein binding: 90%
Half life : 1.6 HOURS
Pka value       : 5.1
Distribution     : crosses placenta, enters breast milk
Tmax : 1 hour
Onset of action : 1-2 HOURS
Elimination  : In urine
Duration of action : 1-1.5 days
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Mechanism of action    :   Suppresses inflammatory and immune responses, mainly by
inhibiting   migration  of  leukocytes  and  phagocytes  and  decreasing  sinflammatory
mediators.
Therapeutic uses:
     Replacement therapy in adrenocortical insufficiency.
     Hypercalcaemia due to cancer.
     Arthritis.
    Collagen diseases.
    Dermatological diseases.
   Autoimmune and haematologic disorders.
   Ulcerative colitis.
   Multiple sclerosis.
   In dental :  Treatment of a variety of oral diseases of allergic, inflammatory or 
                      auto immune origin.
Side effects:
 Stomach upset.
 Head ache.
 Dizziness.
 Menstrual period changes.
 Trouble sleeping.
 Increased appetite.
 Weight gain.
 Pain/redness/swelling at the site of injection.
Contraindications
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• Hypersensitivity to drug, alcohol, bisulfites, or tartrazine (with some products)
• Systemic fungal infections
• Concurrent use of other immunosuppressant corticosteroids
• Concurrent administration of live-virus vaccines
Precautions
 Use cautiously in:
•  hypertension,  osteoporosis,  glaucoma,  renal  or  GI  disease,  hypothyroidism,
cirrhosis, thromboembolic disorders, myasthenia gravis, heart failure
• pregnant or breastfeeding patients
• children ages 6 and younger.
Drug-drug Interactions  :-
Amphotericin B, loop and thiazide diuretics, mezlocillin, piperacillin, ticarcillin :-
additive  hypokalemia
Fluoroquinolones :- increased risk of tendon rupture
Hormonal contraceptives :- prolonged half-life and increased effects of hydrocortisone
Insulin, oral hypoglycemic :- increased requirements for these drugs
Live-virus vaccines :- decreased antibody response to vaccine, increased risk of adverse
reactions
Nonsteroidal anti-inflammatory drugs :- increased risk of adverse GI reactions
Phenobarbital, phenytoin, rifampin :- decreased hydrocortisone efficacy
Somatrem :- inhibition of growth-promoting effect
Dose :-
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Injection                     : 25 mg/ml, 50 mg/ml; 100 mg/vial, 250 mg/vial, 500 
mg/vial, 1,000 mg/vial
Intrarectal aerosol foam   : 90 mg
Oral suspension               : 10 mg/5 ml
Retention enema             : 100 mg/60 ml
Spray (topical)               : 1%
Tablets                          : 5 mg, 10 mg, 20 mg
POLYMER PROFILE
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                                              EUDRAGIT E 100
EUDRAGIT® E  100  is  a  cationic  copolymer  based  on dimethylaminoethyl
methacrylate, butyl methacrylate, and methyl methacrylate. 
Physical  Description: Itconsists  of colourless  to  yellow  tinged  granules  with  a
characteristic amine-like odor.
Chemical structures:
 Product Form: Granules 
Targeted Drug Release Area: Stomach 
Dissolution:
• Soluble in gastric fluid up to pH 5.0
• Swellable and permeable above pH 5.0
Characeristics:
• Low viscosity, high pigment binding capacity, good adhesion
• low polymer weight gain
Chemical/  IUPAC  name: Poly(butyl  methacrylate-co-(2-  demethylaminoeethyl)
methacrylate-co-methyl methacrylate) 1:2:1 
Weight  average  molar  mass: Mw  approx.  47,000  g/  mol 
Alkali Value: 180 mg KOH/ g polymer
Glass Transition Temperature (Tg): ~ 48°C 
Solubility : Soluble in acetone, ethanol, methanol, propanol, dichloromethane. ethyl         
                        acetate. Insoluble in water and petroleum ether.
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Category : Film former, tablet binder, tablet diluent.
Polymer Profile
 Ethyl cellulose (EC)
Synonyms: Aquacoat E-462, Ethocel, Surelease.
Functional category: Coating agent, tablet binder and viscosity increasing agent.
Structural formula:
Description:  Ethyl  cellulose  is  a  tasteless,  free  flowing  white  light  coloured powder.
Solubility:
1.   Ethylcellulose is practically insoluble in glycerin, propylene glycol and water.
2.   EC  that  contains  less  than  46.5%  of  ethoxyl  groups  is  freely  soluble  in 
chloroform, ethanol, ethyl acetate, methanol and toluene.
Melting point: Glass transition temperature – 129-133ºC
Stability and Storage Conditions: Ethyl cellulose is stable, slightly hygroscopic materials.   It
is subjected to oxidative degradation in the presence of sunlight or  UV  light   at   elevated
temperatures.    It  should  not  be  stored  at  temperature exceeding 32ºC (90ºF).
Safety: Ethyl cellulose is widely used in oral and topical pharmaceutical formulations. It is not
metabolized following oral consumption and is therefore a  non-calorific substance.  Ethyl
cellulose is generally regarded as non-toxic, non- allergic and non-irritating material.
Handling  Precautions:  It  is  important  to  prevent  fine  dust  clouds  of  ethyl cellulose from
reaching potentially explosive levels in air.   Ethyl cellulose is combustible.  EC powder may be
an irritant to the eyes and eye protection should be worn
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SODIUM ALGINATE
DEFINITION           :-     Sodium alginate is the sodium salt of alginic acid.
Chemical formula        :-     (C6H7NaO6)n
Structural formula       :-
DESCRIPTION           :- Occurs as white to yellowish brown  amentous,  
grainy, granular or powdered forms
FUNCTIONAL USES :- Stabilizer, thickener, gelling agent,
emulsifier
SOLUBILTY                :- Dissolves slowly in water, forming a viscous 
solution; insoluble in ethanol and ether
DENSITY                     :- 1.601 g/cm3 
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HYDROXY PROPYL METHYL CELLULOSE
It is a mixed alkyl hydroxy alkyl cellulose ether and may be regarded as propylene
glycol of methylcellulose.
where R is H, CH3  or [CH3CH(OH)CH2]
Chemical name : Cellulose, 2-hydroxypropyl methyl ether.
Emperical formula : C8H15O6 - (C10-H18O6)n – C8H15O5.
Grades : Methocel - E5, E15, E50, E4M, F50, F4M, K 100, K4M, K15M, K 100M.
Description :  Odourless,  tasteless,  white  or  creamy  fibrous  or  granular  powder.
Molecular weight: Approximately 86.000.           
 Density : 0.25 - 0.70 gm/cm3
Viscosity : HPMC E15 CPS (2% aqueous solution, HPMC EYM 4000 CPS aqueous
solution).
pH : 6.0-8.0 (1% aqueous solution).
Solubility: Soluble in cold water, forming a viscous colloidal solution. Insoluble in
ether, alcohol and chloroform.   But soluble in mixtures of methanol and methylene
chloride.  Certain  grades  are  soluble  in  aqueous  acetone,  mixtures  of  methylene
chloride and isopropyl alcohol and other organic solvents.
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Stability : Very stable in dry conditions.
Safety : Hydroxy propyl methyl cellulose has been shown to be safe in humans and in
animals.
Incompatibility : It is incompatible at extreme pH conditions and in the presence of
oxidizing materials.
Applications : It is used as suspending, viscosity increasing and film forming agent. It is
also used as a tablet binder and as an adhesive ointment ingredient.  The E grades are
generally suitable as film formers and K grades are used as thickeners.
Ultra college of pharmacy, Madurai Page 47
MATERIALS AND METHODS
CARBOPOL 940 LR
Chemical structure :-
SYNOYM : Carbomer
Chemical  name  :  Carboxyvinyl  Polymer;  average  equivalent  weight:  ca.76;  Bulk
density: 0.20-0.23 g/cm3; pH (0.5% water dispersion): 2.7-3.5
Carbomer is a fine white acrylic powder used in hair gels, and other gels, lotions, and
creams. 
It is suitable for formulating sparkling and clear gels as well as stabilizing emulsions. The
typical  use level is  0.1-0.5% depending o n the type of formulation and final  desired
viscosity.
It is a cost effective thickener and is pH sensitive. Carbomer must be thoroughly mixed
and hydrated. Increasing the pH to 7.0, gives a gel structure. Neutralization can be carried
out with inorganic bases (such as NaOH, KOH, NH4OH) or with organic amines (such as
TEA, AMP, AMPD). To neutralize 1 g of Carbomer to pH 7, ca. 0.01 equivalent of base
are required (e.g. 0.4g of NaOH, 0.9g of AMP, 1.5g of TEA). It is advisable to add strong
bases previously diluted into water at a concentration not higher than 10%.
Solubility : Soluble in water, alcohol and glycerine.
Stability : Gel loses viscosity upon exposure to sunlight.  It is relatively unaffected by   
                  temperature variations and is resistant to bacterial growth.
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Safety : It  is  safe and non-toxic.  No primary irritation or  allergic  reaction in  human
beings upon topical application. It is not absorbed in the body and is excreted unchanged.
It  contributes  no  off-taste  and  in  some  cases  may  mask  the  undesirable  taste  of
formulation.
    TAMARIND GUM
Synonyms    : Tamarindus indica linn.
Molecular  weight : Within the range of 2.5×105 and 6.5×105.
Structural Formula :
                  
Functional category : stabilizer,thickener,gelling agent,and binder in food 
and pharmaceutical industries.
Pharmaceutical application   :
• Dissolution improvement
• Nasal mucoadhesion
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METHODS
PREPARATION OF STANDARD CURVE OF HYDROCORTISONE  
                                     SODIUM SUCCINATE41.
Procedure  :-
                 The accurately weighed quantity of  100 mg of  hydrocortisone sodium
succinate was dissolved in 100 ml of phosphate buffer pH(6.8) as stock solution A and
then from this solution 1ml was pippeted out and diluted with phosphate buffer (pH6.8)
up to100ml,this  solution as  stock  solution B 1,  2,  3,  4,  5  ,  6,  7,  8,  9,and ml  10  ml
pipettedin  different  10ml  volumetric  flasks.  These  were  finally  diluted  up  to  10ml
phosphate buffer (pH 6.8).
Absorbance of each of these was recorded at 249 nm.
The absorbance was plotted against concentration; a straight line passing through
origin  was  obtained  which  indicate  that  concentration  of  dilutions  obeys  the  Beer-
Lamberts law
PREPARATION OF TAMARIND SEED POLYSACCHARIDE SOLUTION.
Take the required quantity of tamarind in distiiled water and boiled in water bath.
After that the solution keep in 24hrs and filtered this solution.
FABRICATION OF BUCCAL PATCHES.
 The patches were prepared by solvent casting.
SOLVENT CASTING METHOD
In this method, all patch excipients including the drug co-dispersed in an organic
solvent and coated onto a sheet of release liner. After solvent evaporation a thin layer of
the protective backing material is laminated onto the sheet of coated  release liner to form
a laminate that is die-cut to form patches of the desired size and geometry.
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FABRICATION OF DRUG MATRIX DEVICE
For  the  formulation  D1  and  D2  accurately  weighed  quantity  of  hydrophobic
polymer Eudragit E 100 dissolved in isopropyl alcohol and acetone in the ratio of  6:4.
The accurately weighed quantity of  hydrocortisone sodium succinate dissolved in the
above polymer solution, the solution was mixed according to required proportion. The
required quantity of poly ethylene glycol 400 was added as plasticizer, after which the
solution was poured in to the petridish and it is dried in the drier.
FABRICATION OF MUCOADHESIVE LAYER 
Mucoadhesive polymers are sodium alginate, tamarind gum and carbapol,  HPMC
combination which are dissolved in water and added glycerine as a plasticizer. Then the
solution are poured in the petridish and kept in vaccum oven.
FABRICATION  OF  BACKING MEMBRANE.
The backing membrane used as ethyl cellulose film in which ethyl cellulose is
dispersed in toluene and glycerine as plasticizer.
FABRICATION OF BUCCAL LAMINATES.
The laminates was prepared by using the drug loaded film placing between the
mucoadhesive layer and the backing membrane.
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Table 1: COMPOSITION OF BUCCAL PATCHES LAMINATE
FORMULATIONS.
Formulation code                    D1
                (mg)
                    D2
                   (mg)
Hydrocortisone sodium    
            Succinate
                10                    10
 Eudragit E 100                 625                    1250
Poly ethylene glycol 400                187.5                   375
Isopropyl alcohol                6ml                    6ml
  Acetone                 4ml                       4ml
Table 2: COMPOSITION OF  MUCOADHESIVE LAYER
Formulation code M1 (mg) M2 (mg) M3 (mg)
Sodium alginate 300 _ _
Tamarind _ 200 _
Carbopol 940 _ _ 80
HPMC _ _ 150
Glycerine 120 120 120
Distilled water 10ml 10ml 10ml
Table 3: COMPOSITION OF BUCCAL PATCHES
Formulation 
  code
 F1 F2 F3 F4 F5 F6
Drug matrix D1 D2 D1 D2 D1 D2
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formulation
Mucoadhesiv
e
    layer
M1 M1 M2 M2 M3 M3
Backing 
membrane
EC EC EC EC EC EC
PHYSICO-CHEMICAL EVALUATION OF PATCHES
Weights:
Each patch was weighed individually on electronic balance and average weight of
three patches was found.
Thickness:
The thickness of each patch was measured using screw gauge at  five different
positions of the patch and the average was calculated.
Folding endurance of the patches:
Folding endurance of the patch was determined by repeatedly folding one patch at
the same place till it broke or folded up to 300 times manually, which was considered
satisfactory to reveal good patch properties. The number of times of patch could be folded
at the same place without breaking gave the value of the folding endurance. This test was
done on fivepatches.
Surface pH:
Buccal patches were left to swell for 2h o the surface of the agar plate, prepared
by dissolving 2 %(w/v) agar in warmed isotonic phosphate buffer of pH 6.8 under stirring
and  then  poured  the  solution  into  the  petridish  allowed  to  stand  till  gelling  at  room
temperature. The surface pH was measured by means of pH paper placed on the surface
of the swollen patches. 
Drug content:
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The  patch  allowed  to  dissolve  100ml  isotonic  phosphate  buffer,  pH  6.8.  The
amount  of  hydrocortisone  sodium  succinate  in  patch  was  measured
spectrophotometrically at גmax of 249nm.
Swelling studies:
A drug loaded patch was weighed and kept in a 2% agar plate,after every 1 hour,
the  patch  was  removed  and  wiped  with  tissue  paper  and  weighed  upto  3  hrs.  The
difference  in  the  weights  gives  the  weight  increase  due  to  absorption  of  water  and
swelling of patch. 
Tensile strength of the patches:
Tensile  strength  of  the  patch  was  determined  with  universal  strength  testing
machine. The sensitivity of the machine is 1 gram. It consists of two load cell grips. The
lower one is fixed and the upper one is movable. The test patch was fixed between the
cell grips and the force was gradually till the film broke. The tensile of the patch was
taken directly from the dial reading in kg47, 48, 49.  
In-vitro release studies of films by using dissolution apparatus:
The release study was carried out in a USP dissolution apparatus type VI .The
dissolution medium was 500ml phosphate buffer pH 6.8 ,maintained at 370C and  kept in
a glass beaker fixed inside the USP dissolution flask.The patch was fixed to the central
axis,which  rotated  at  50  rpm.Filtered  samples  2ml  were  withdrawn  at  intervals  of
30,60,90,120,180,240, and 300min.The concentration of drug released in the medium was
assayed spectrophotometrically at 249 nm after suitable dilution with the dilution medium
when necessary.
In-vitro buccal permeation study:
             In vitro study of hydrocortisone sodium succinate permeation through goat buccal
mucosa was performed using a modified glass diffusion cell.Goat buccal mucosa was
obtained from a local slaughter house .Goat buccal mucosa mounted between the donor
compartment and receptor compartment so that the smooth surface of the mucosa faced
the donor compartment. The patch was placed on the mucosa;the donor compartment was
filled with 15ml of phosphate buffer pH6.8.The donor compartment fixed such that  it
touches surface of receptor compartment(15ml capacity).The receptor compartment was
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filled with phosphate buffer  pH 7.4 and hydrodynamic in the receptor compartment was
maintained by stirring with a magnetic bead at 100 rpm. 2ml sample was withdrawn at
specific time interval and analyzed for drug content at 249nm.The sample withdrawn  was
analyzed by UV spectrophotometer.
Ex-vivo mucoadhesion study:
Mucoadhesive  strength  of  the  patch  was  determined  with  universal  strength  testing
machine. It consists of two load cell grips. The lower one is fixed and the upper one is
movable. The test patch was fixed in the upper moved probe and the goat buccal mucosa
was fixed in the lower cell which is moistened with the phosphate buffer pH6.8.The test
patch was stucked to the lower side of the buccal mucosa. The mass required to detach the
patches from the mucosal surface gave the measure of mucoadhesive strength50, 51.
IN-VIVO COMPATABILITY STUDY :
Procedure for in-vivo compatibility study on human volunteers:
       Informed conset was obtained from all human volunteers before conducting study.
The  study was  conducted  on  10  human  volunteers.  Volunters  were  given  formulated
hydrocortisone sodium succinate buccal patch and evaluate any discomfortable, heaviness
or any irritations of the given patches.
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Fig 6: Tensile strength tes using texture analyser
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Fig 7: Invitro drug release in dissolution apparatus USPII 
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Fig 8: Mucoadhesion test using texture analyser
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Fig 9: Ex-vivo permeation study
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PREPARATION OF STANDARD CURVE OF HYDROCORTISONE  
                                     SODIUM SUCCINATE.
Table 4: Absorbance values of  Hydrocortisone sodium suucinate in phosphate
buffer (pH 6.8)
                Sl.
no
         Concentration 
               (mcg/ml)
    Absorbance
                  1                  0                 0
                  2                 1               0.07
                  3                 2               0.121
                  4                 3               0.170
                  5                4               0.310
                  6                5               0.320
                  7                6               0.380
                  8                7               0.409
                  9                8               0.520
                 10                9               0.612
                 11               10               0.670
STANDARD GRAPH OF HYDROCORTISONE SODIUM
SUCCINATE
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Graph 1: Calibration curve of hydrocortisone sodium  succinate
Drug- Excipient compatibility study
   FT-IR Spectra for Hydrocortisone Sodium  Succinate
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FT-IR Spectra for Eudragit EPO
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   FT-IR Spectra for Hydrocortisone Sodium  Succinate + Eudragit EPO
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PHYSICO-CHEMICAL EVALUATION OF PATCHES
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Weight  uniformity:
Weight uniformity for formulation D1 and D2 varied from 116 to 192mg and formulation
F1 to F6 varied from 15.8 to 53mg. The patches were found to be weight  uniform due to
increasing the concentration of polymer.
Thickness:
As the total  amount of  polymer increases the thickness of the film were found to be
increased. The thickness of the formulation D1 and D2 varied from 263 to 326µm and
formulation F1 to F6 varied from 74 to 112µm, D2 having more thickness due to more
concentration than D1.
Folding endurance
As the amount of plasticizer increases the folding endurance was found to be increases.
All  the patches  exhibited folding endurance above 200 proving the flexible nature of
patches due to the presence of the plasticizer.
Surface pH
The surface pH of the patches was between 5 to 5.5 which are due to the pH of the drug
and polymer, hence no mucosal irritations was expected and ultimately achieves patient
compliance. 
Drug content
All the batches of the patches exhibit drug content within limit 86.28 to 91.06% which is
within the desirable range due to the equal distribution of drug in the solution.
Swelling index.
Swelling of formulation was done on phosphate buffer  pH 6.8 .In the formulation D1 and
D2.
D2  having good swelling property than  D1.In  the  mucoadhesive  films,  the  swelling
property more in carbapol and HPMC  than others.
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Table 5: Physicochemical evaluation of buccal patches
Formulatio
n  
    code
    Weight 
uniformity(m
g)
Thicknes
s
   (µm)
Folding 
enduranc
e
Surface 
pH
Content 
uniformity
Swelling 
index
D1
116 ±0.67 263±0.11 229±2 5.5±0.0
1
91.06±2.6
7
0.6257±0.2
D2
192±0.24 326±0.33 248±5 5.5±0.0
1
86.28±3 1.2793±0.1
4
Table 6: Physicochemical evaluation of mucoadhesive films.
     
  
                                                    
Table 7: Tensile strength
       Formulation code   Extensibility (mm)      Tensile strength (N)
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    code
    Weight 
uniformity(mg)
Thickness
   (µm)
Folding 
endurance
Swelling 
index
Sodium 
alginate
          
   53±0.51 112±2 200±5 0.7623±0.13
Carbapol + 
HPMC   31.1±0.21  82±1
201±8
0.9718±0.21
Tamarind 15.8±0.011 74±1 219±3 0.5212±0.54
RESULT AND DISCUSSION
                  D1         2.346               6.278
                  D2        1.234               7.747
Graph 2: Tensile strength of D1 and D2.
IN-VITRO DRUG RELEASE
The results of drug release studies are presented in the table and the graphs
Hydrocortisone sodium succinate buccal patch were prepared with eudragit E100 polymer
having different concentration. All the patches the drug released within 5hrs.
Here the drug release was carried out and concluded that the 0.625 gm of eudragit E 100
having 84%  drug release within 5hrs than 74.36 % of the 1.25gm of eudragit E 100
polymer.
Table 8: In-vitro hydrocortisone sodium succinate release for batch D1
Cumulative amount of drug release Cumulative% of drug 
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  Time (min)                  (mg) release
0 0 0
30  0.812 16.24
60 0.954 19.08
90 1.109 22.18
120 1.821 36.42
180 2.212 44.24
240 3.011 60.22
300 4.200 84
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Graph 3: In-vitro drug release D1.
Table 9: In-vitro hydrocortisone sodium succinate release for batch D2
 Time in minute  Amount of drug release   
              (mg)
Cumulative % drug 
release
          0            0           0
          30            0.645                   12.9
          60            0.825         16.5
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          90            1.015         20.3
          120            1.521         30.42
          180            2.011         40.22
          240            2.578         51.56
          300           3.718         74.36
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Graph 4: In-vitro drug release D2.
CUMULATIVE AMOUNT OF DRUG RELEASES FOR D1 AND D2
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Graph 5: Correlation graph between D1 and D2
EVALUATION OF MUCOADHESION
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RESULT AND DISCUSSION
      
      CODE
     
     Patch tested
  
    ADHESIVE   
     FORCE(N)   
WORK OF 
ADHESION
   (N SEC)
DEBONDIN
G DISTANCE
(mm)
       M3  Carbopol+HPMC           0.0873   0.98066 11.14
       M1  Sodium alginate           0.016 0.0883 0.560
       M2    Tamarind Gum          0.024 0.141 1.208
Table 10: Mucoadhesion was determined at 0.05N force and 90 sec
contact time.
 Patch tested Applied force Ahesive force  
        (N)
Work of 
adhesion 
 (N SEC)
Debonding
Distances
   (mm)
Laminate      0.05   0.033 1.157 5.66
Laminate      0.1 0.039 1.177 6.004
Laminate      3.5 0.1667 1.883 4.072
Table 11: Parameters of mucoadhesion testing with Texture analyser
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Graph 6: Graph of mucoadhesion of carbapol + HPMC
Graph 7: Graph of mucoadhesion of sodium alginate
Graph 8: Graph of mucoadhesion of  Tamarind.
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Graph 9: Graph of mucoadhesion of laminte 0.05N.
Graph 10: Graph of mucoadhesion of laminate 0.1N
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Graph 11: Graph of mucoadhesion of laminate 3.5N.
 IN-VITRO  BUCCAL PERMEATION  STUDIES.
In-vitro  buccal  permeation  study was  carried  out  ,  the  permeation  study  was
carried out by using freshly excised goat buccal mucous membrane. The in-vitro drug
permeation was 76% for 4hrs in F5 formulation.
Table 12: Invitro hydrocortisone sodium succinate permeation for batch  F1.
Time in minute Amount of drug release 
(mg)
Cumulative % drug release
0 0 0
30 0.54 21.6
60 0.65 26
90 0.71 28.4
120 0.83 33.2
180 0.92 36.8
240 1.2 48
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Table 13: Invitro drug permeation for batch F3
Time in minute Amount of drug release
            (mg)
Cumulative % drug     
           Release
0 0 0
30 0.59 23.6
60 0.71 28.4
90 0.88 35.2
120 0.97 38.8
180 1.23 49.2
240 1.30 52
                                     
Table 14: Invitro drug permeation of drug for batch F5
Time in minute Amount of drug release
            (mg)
Cumulative % drug     
           Release
0 0 0
30 0.83 33.2
60 1.03 41.2
90 1.27 50.8
120 1.58 63.2
180 1.79 71.6
240 1.90 76
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Graph 12: Correlation of the invitro permeation for F1, F3 AND F5.
             
Table 15: Invitro drug permeation for batch F2.
Time in minute Amount of drug release
            (mg)
Cumulative % drug     
           Release
0 0 0
30 0.43 17.2
60 0.51 20.4
90 0.59 23.6
120 0.63 25.2
180 0.79 31.6
240 0.90 36
Table 16: Invitro drug permeation for batch F4
Time in minute Amount of drug release Cumulative % drug     
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            (mg)            Release
0 0 0
30 0.58 23.2
60 0.62 24.8
90 0.79 31.6
120 0.92 36.8
180 1.10 44
240 1.30 52
Table 17: Invitro drug permeation for batch F6
Time in minute Amount of drug release
            (mg)
Cumulative % drug     
           Release
0 0 0
30 0.73 29.2
60 0.89 35.6
90 1.12 44.8
120 1.40 56
180 1.53 61.2
240 1.70 68
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Graph 13: Correlation of  the invitro permeation study for the batch F2, F4 and F6.
                     INVIVO  COMPATABILITY  STUDIES.
Invivo evaluation of the buccal patches in human healthy volunteers revealed that
no irritations, no heaviness and good mouth feel  was observed. This further confirms
successful formulation of hydrocortisone sodium succinate in the form of buccal patch.
None of  the formulations were detached from the oral  mucosa over the study period,
which indicated that the bioadhesion values of the formulations were satisfactory to retain
the film on the buccal mucosa.
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Buccal  tablets  ,  lozenges  and  pastes  are  used  in  relieving  pain,  inflammation
associated with oral mucosal diseases like inflammations, oral submucous fibrosis, ulcer,
and other lesions. Hydrocortisone sodium succinate is used as an anti inflammatory agent.
The most important advantage of the mucoadhesive buccal films is that it contains
a lower drug dose, adequate for therapeutic effect as it is placed directly on the site of the
inflammation, when compared to conventional administration. Moreover,  mucoadhesive
buccal patches are convenient and comfortable to use as they are  non-irritant and self
administration is possible.
In the present work successful attempt was made to formulate  buccal strips using
10 mg drug loaded in eudragit E100 polymer and PEG 400 is used as a plasticizer. The
formulations  are  D1  and  D2,  D1  was  to  releases  84  %  of  drug  within  5hrs.In  the
formulations D1 and D2 carried all the physicochemical evaluations and it was found to
be within the limits.
In the formulations F1, F2, F3, ,F5 and F6 the in-vitro diffusion study was carried
out, the F5 showed maximum drug  permeation through the buccal mucosa of the goat.
All the physico chemical parameters done in this formulations and it was found to be
within the limits.
The optimized formula F5 was carried out the in-vivo compatibility study it was
not found that to produce irritation, discomfort able or heaviness. This F5 was detached
from the oral mucosa over the study period
The FTIR characterization of hydrocortisone sodium succinate with Eudragit E
100 blend indicates no interaction between them.
Thus present attempt of developing hydrocortisone sodium succinate buccal patch
laminate has been ac.omplished with satisfactory results.
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